Back
Summit Therapeutics Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57
SMMT
Summit Therapeutics
Last Price:
18.44
Seasonality Move:
33.32%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Summit Therapeutics Price Quote
$18.44
-0.18 (-0.97%)
(Updated: November 21, 2024 at 5:55 PM ET)
Summit Therapeutics Key Stats
Buy
57
Summit Therapeutics (SMMT)
is a Buy
Day range:
$18.31 - $19.97
52-week range:
$1.89 - $33.89
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
14,085.25
P/B ratio:
31.96%
Volume:
1.8M
Avg. volume:
2.2M
1-year change:
835.68%
Market cap:
$14B
Revenue:
$0
EPS:
$-0.24
How Much Does Summit Therapeutics Make?
Data Unavailable
Is Summit Therapeutics Growing As A Company?
Data Unavailable
Summit Therapeutics Stock Price Performance
-
Did Summit Therapeutics Stock Go Up Last Month?
Summit Therapeutics share price went down by -12.21% last month -
Did SMMT's Share Price Rise Over The Last Year?
SMMT share price rose by 835.68% over the past 1 year
What Is Summit Therapeutics 52-Week High & Low?
-
What Is Summit Therapeutics’s 52-Week High Share Price?
Summit Therapeutics has traded as high as $33.89 over the past 52 weeks -
What Is Summit Therapeutics’s 52-Week Low Share Price?
Summit Therapeutics has traded as low as $1.89 over the past 52 weeks
Summit Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Summit Therapeutics?
-
How Much Debt Does Summit Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Summit Therapeutics Have?
Cash and short term investments quarterly total is $486.9M -
What Is Summit Therapeutics’s Book Value Per Share?
Book value per share is 0.59
Is Summit Therapeutics Cash Flow Positive?
-
What Is SMMT Cash Flow From Operations?
Cash flow from operations (TTM) is -$112.9M -
What Is Summit Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $411.1M -
What Is Summit Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$228.3M
Summit Therapeutics Return On Invested Capital
Data Unavailable
Summit Therapeutics Earnings Date & Stock Price
-
What Is Summit Therapeutics's Stock Price Today?
A single share of SMMT can be purchased today for 18.62 -
What Is Summit Therapeutics’s Stock Symbol?
Summit Therapeutics trades on the nasdaq under the ticker symbol: SMMT -
When Is Summit Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Summit Therapeutics is scheduled on February 20, 2025 -
When Is SMMT's next ex-dividend date?
Summit Therapeutics's next ex-dividend date is November 21, 2024 -
How To Buy Summit Therapeutics Stock?
You can buy Summit Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Summit Therapeutics Competitors
-
Who Are Summit Therapeutics's Competitors?
Below is a list of companies who compete with Summit Therapeutics or are related in some way:
Summit Therapeutics Dividend Yield
-
What Is SMMT Dividend Yield?
Summit Therapeutics’s dividend yield currently is 0% -
What Is Summit Therapeutics’s Payout Ratio?
Summit Therapeutics’s payout ratio is 0% -
When Did Summit Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 21, 2024 -
What Is Summit Therapeutics’s Dividend Per Share?
Summit Therapeutics pays a dividend of $0.00 per share
Summit Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -19.41% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 34.70 |
| Upside from Last Price: | 86.36% |